Analgesics in South Korea

Analgesics in South Korea

Analgesics is set to maintain solid retail current value growth in South Korea in 2024. Paediatric analgesics, especially paediatric ibuprofen, is expected to see the strongest growth, followed by adult Ibuprofen, with increases in the double digits. Consumers’ purchasing patterns have become more sophisticated, particularly during the influenza season, when many outlets face stock shortages. Liquid formats of paediatric acetaminophen sell better than tablet formats. However, during these times,...

Euromonitor International's Analgesics in South Korea report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.